Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tyrosine kinase receptors (RTKs) are high-affinity cell surface receptors for polypeptide growth factors, cytokines, and hormones. They regulate cell proliferation, differentiation, metabolism, survival, and migration. Ligand binding induces dimerization and autophosphorylation, activating downstream signaling pathways like Ras/MAPK, PI3K/AKT, and PLCγ. Dysregulation is implicated in cancers and other diseases, making them important therapeutic targets.
Inhibition of tyrosine kinase activity, blocking downstream signaling pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosine Kinase Receptors (RTKs).